Search results
Pfizer Stock Gets Boost From Better-Than-Expected Earnings
Investopedia· 6 hours agoNet income was 44% lower at $3.12 billion, or 55 cents per share from last year's mark of $5.54...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 8 hours agoSI&A spending is expected in the...billion. The adjusted tax rate is expected to be approximately 15...
Covid-19 Vaccination Associated With Reductions In Pediatric Cases And Hospitalizations
Forbes· 7 days agoA California-based study found that thanks to the state’s Covid-19 immunization program, there was a...
Pfizer Lifts 2024 Profit View on Cost Cuts, Higher COVID Vaccine Demand
US News & World Report· 13 hours agoUS News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 7 hours agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
CNBC· 13 hours agoPfizer on Wednesday reported first-quarter revenue that beat expectations and hiked its full-year...
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 5 hours ago, opens new tab lifted its annual earnings forecast on Wednesday and reported a first-quarter profit...
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To...
Benzinga via Yahoo Finance· 7 hours agoThe company witnesses a significant decrease in Comirnaty and Paxlovid revenues globally and an...
We May Be Facing an Epidemic of This Brain Disease
Mercola· 3 days agoIn my 2021 interview with Stephanie Seneff, Ph.D., she explained why she suspected the COVID shots may eventually result in an avalanche of neurological prion-based diseases ...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 19 hours agoPfizer’s $0.55 diluted earnings per share and $14.9 billion in first...2024 guidance of $58.5...